Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03533101 Completed - Clinical trials for Stem Cell Transplant Complications

Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation

Start date: May 25, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Tocilizumab will be administered prior to transplantation in order to prevent the onset of cytokine release syndrome and its complications associated to peripheral blood haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

NCT ID: NCT03532945 Completed - Clinical trials for Degenerative Lumbar Spinal Stenosis

A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody Fusion

Start date: October 28, 2010
Phase: N/A
Study type: Interventional

This is a long-term follow-up study for more than 3 years to evaluate the efficacy and safety of bioactive glass-ceramic intervertebral spacer (Novomax) in posterior lumbar interbody fusion.

NCT ID: NCT03532724 Completed - Clinical trials for Self Management of Oral Anticoagulation With VKA Therapy

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

ORION
Start date: November 1, 2017
Phase:
Study type: Observational

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)

NCT ID: NCT03532230 Completed - Clinical trials for Lumbar Spinal Stenosis

Cost Effectiveness of OMT for Chronic Low Back Pain

Start date: March 22, 2019
Phase:
Study type: Observational

The specific aim of this study is to conduct a prospective, multicenter cohort study over four months to compare the cost of standard of allopathic care (control group, N=90) versus standard of care plus osteopathic manipulative treatment (experimental group, N=90) in a cohort of 180 consecutive patients seeking treatment for chronic low back pain at three osteopathic clinics and three allopathic medical clinics (offering only standard care) located in three different regions of the United States.

NCT ID: NCT03532217 Completed - Clinical trials for Metastatic Hormone-Sensitive Prostate Cancer

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Start date: September 14, 2018
Phase: Phase 1
Study type: Interventional

This study study aims to elucidate the immune responses to a shared antigen vaccine (PROSTVAC) and tumor specific antigens generated DNA vaccine in combination with checkpoint blockade using nivolumab (anti-PD-1), and ipilimumab (anti-CTLA-4). Additionally, the investigators will study the impact of the combination immunotherapy on peripheral T cell activation, as well as immune response in the tumor microenvironment. Finally, the investigators will evaluate the safety and tolerability to this novel personalized immunotherapy in combination with checkpoint blockade.

NCT ID: NCT03531996 Completed - Clinical trials for Autoimmune Pulmonary Alveolar Proteinosis

The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

LongPAP
Start date: April 19, 2018
Phase:
Study type: Observational

The major goal of this study is to conduct a prospective, longitudinal study of autoimmune PAP to examine outcome measures for disease severity of potential use in clinical practice and/or clinical research studies. These results will impact the field by: 1) improving an understanding of the clinical course of autoimmune PAP, 2) providing information on various clinical outcome and quality of life outcome measures to guide patients and physicians in making treatment choices, and 3) facilitate the development of pharmaco-therapeutics for autoimmune PAP and 4) better informing PAP researchers.

NCT ID: NCT03531697 Completed - Clinical trials for Inflammation Following Ocular Surgery

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

Start date: April 26, 2018
Phase: Phase 1
Study type: Interventional

This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)

NCT ID: NCT03530631 Completed - Clinical trials for Expectancy Versus Pharmacotherapy Effect of Adderall

Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance

Start date: November 10, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this balanced-placebo design study is to pilot a larger study to further explore the current evidence that stimulant medications are not cognitive enhancers, despite this rampant belief in young adults. While the lack of cognitive enhancement from stimulant medication has been documented in prior research, this study is the first to utilize neuroimaging technology to examine brain regions activated during neurocognitive tasks when participants believe they have been administered stimulant medication or placebo.

NCT ID: NCT03530436 Completed - Clinical trials for Safety After Oral Intake

Comparison of Curcumin Bioavailability

Start date: June 7, 2018
Phase: N/A
Study type: Interventional

The curcuminoids curcumin, demethoxycurcumin and bisdemethoxycurcumin can be found in the rhizome of turmeric (Curcuma longa). Curcumin is widespread used for colouring foods. Based on its natural low bioavailability and the number of its effects on human health, several approaches such as increasing its water solubility or inhibiting its metabolism were taken to improve its bioavailability. Pharmacokinetics of curcumin from various supplements using those different mechanisms have been compared to the one of native curcumin. The investigator's study here will compare the bioavailability of curcumin from eight different curcumin formulations with native curcumin and between themselves. The study will folllow a single dose (in form of curcumin formulations, normalized to 207 mg curcumin), placebo-controlled, randomized, double-blind, nine-armed crossover study design with ≥ 1-week washout periods. Plasma samples will be collected at intervals up to 24 hours after intake. Investigators will compare the pharmacokinetics between the different curcumin formulations and to native curcumin.

NCT ID: NCT03530280 Completed - Clinical trials for Postoperative Pain After Knee Arthroscopy

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

arthroscopically Anterior Cruciate Ligament Reconstruction (ACL) under spinal anesthesia were included in this study.